NCT06987799 Community-based Approach to Lowering Stress Through Mindfulness
| NCT ID | NCT06987799 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-09-10 |
| Primary Completion | 2028-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-09-10 with a primary completion date of 2028-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test a culturally adapted mindfulness-based stress reduction intervention in a community setting for African American adults with high blood pressure (hypertension) and depression. The main questions it aims to answer are: * Does participation in a culturally adapted mindfulness-based intervention improve depressive symptoms? * Does participation in a culturally adapted mindfulness-based intervention improve blood pressure control? * Is the intervention acceptable, appropriate, and feasible as delivered in a community setting? Participants will: * Participate in an 8-week group-based mindfulness intervention (CALM-Chicago). During intervention sessions, participants will learn about mindfulness and stress management and complete mindfulness-based activities, such as guided deep breathing and meditation. * Complete surveys online * Have their blood pressure measured with a non-invasive blood pressure cuff * Attend 1 focus group (optional)
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * Lives, works, or spends much of their time in the South Side of Chicago neighborhood * Self-reports diagnosis of hypertension or high blood pressure by a clinician * Endorses elevated depressive symptoms as Patient Health Questionnaire (PHQ)-9 scores ≥10 * Not taking antidepressant medication or stable on antidepressant medication for ≥6 months as self-reported Exclusion Criteria: * \<18 years old * Severe mental illness (e.g., bipolar disorder, psychosis) * Current suicidal ideation (PHQ-9 item 9) or recent (past 6 months) suicide attempt * Unable to provide informed consent or complete study activities in English
Contact & Investigator
Allison J Carroll, PhD
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT06987799 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06987799 currently recruiting?
Yes, NCT06987799 is actively recruiting participants. Contact the research team at asia.ellis@northwestern.edu for enrollment information.
Where is the NCT06987799 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06987799 clinical trial?
NCT06987799 is sponsored by Northwestern University. The principal investigator is Allison J Carroll, PhD at Northwestern University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.